Skip to main content
Equibles

Squarepoint Ops LLC

Position in JNJ — Johnson & Johnson

CIK 1642575 NEW YORK, NY
Back to JNJ Full portfolio

Position in JNJ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$316,720,653
+$138,525,605 QoQ
Shares Held
1,247,079
+71.1% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#150
of 4,659 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Derivatives in JNJ

reported options exposure · as of Jun 30, 2026
CallValue
$62,171,856
CallShares
244,800
PutValue
$32,762,130
PutShares
129,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,171,914,058 across 14 Drug Manufacturers - General names. JNJ ranks #1 (27.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JNJ
Johnson & Johnson
This page 		1,247,079 $316,720,653
2 LLY
ELI LILLY & Co
 245,569 $294,542,850
3 GILD
Gilead Sciences, Inc.
 1,823,224 $230,346,120
4 MRK
Merck & Co., Inc.
 909,676 $116,893,366
5 PFE
Pfizer Inc
 3,310,002 $79,704,848
6 AMGN
Amgen Inc
 208,010 $75,324,581
7 ABBV
AbbVie Inc.
 91,950 $23,138,298
8 BMY
Bristol Myers Squibb Co
 324,626 $18,704,950

All Filings in JNJ

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $62,171,856 244,800
2026-06-30 $32,762,130 129,000
2026-06-30 $316,720,653 1,247,079
2026-03-31 $62,454,420 255,500
2026-03-31 $178,195,048 728,993
2026-03-31 $102,298,140 418,500
2025-12-31 $59,539,515 287,700
2025-12-31 $65,964,484 318,746
2025-12-31 $101,633,145 491,100
2025-09-30 $25,680,670 138,500
2025-09-30 $104,621,009 564,238
2025-09-30 $90,410,792 487,600
2025-06-30 $19,475,625 127,500
2025-06-30 $151,146,125 989,500
2025-06-30 $11,056,045 72,380
2025-03-31 $45,672,667 275,402
2025-03-31 $72,472,080 437,000
2025-03-31 $16,982,016 102,400
2024-12-31 $72,107,532 498,600
2024-12-31 $143,792,195 994,276
2024-12-31 $39,293,254 271,700
2024-09-30 $36,155,586 223,100
2024-09-30 $4,634,916 28,600
2024-09-30 $47,058,820 290,379
2024-06-30 $5,671,008 38,800
2024-06-30 $162,428,777 1,111,308
2024-06-30 $1,651,608 11,300
2024-03-31 $22,273,152 140,800
2024-03-31 $17,479,995 110,500
2024-03-31 $208,175,825 1,315,986
2023-12-31 $4,545,460 29,000
2023-12-31 $1,567,400 10,000
2023-12-31 $118,968,951 759,021
2023-09-30 $101,083,307 649,010
2023-09-30 $14,219,975 91,300
2023-09-30 $2,523,150 16,200
2023-06-30 $71,394,072 431,332
2023-06-30 $5,511,816 33,300
2023-06-30 $7,564,264 45,700
2023-03-31 $8,308,000 53,600
2023-03-31 $7,564,000 48,800
2023-03-31 $52,019,240 335,608
2022-12-31 $1,572,185 8,900
2022-12-31 $27,357,432 154,868
2022-12-31 $4,804,880 27,200
2022-09-30 $1,599,131 9,789
2022-09-30 $5,848,288 35,800
2022-09-30 $5,374,544 32,900
2022-06-30 $4,384,497 24,700
2022-06-30 $3,047,669 17,169

Report a Problem

Category
Description
Email (optional, for follow-up)